EUVIMEDEUVIMED entdecken
Crossref

Evidence for Complement Activation in Preeclampsia Placenta and Its Presence in Circulation

Shibin Cheng iD, Wendy Norris, Satyan Kalkunte, Sukanta Jash, Lauren R Richardson iD, Surendra Sharma iD

American Journal of Reproductive Immunology · 2025

DOI: 10.1111/aji.70076 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Reproductive Immunology, 2025. Verfasst von Shibin Cheng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA. Hauptthemen laut MEDLINE: Pre-Eclampsia, Complement Activation, Placenta, Trophoblasts. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Problem Preeclampsia (PE) is a severe pregnancy disorder caused by a multitude of dysregulated events, including placental insufficiency, inflammation, anti‐angiogenic factors, and cellular stress signals. Inflammatory activation of the complement cascade has also been thought to be a contributory factor to PE pathophysiology. However, the placental and circulating presence of activated complement factors and their precise impact on gestational age‐dependent trophoblast health remain inadequately addressed. Method of Study Complement activation was assessed in placental tissue samples from women with normal pregnancy (NP) and PE. Immunofluorescent staining was employed to detect the membrane attack complex (MAC) deposition in placental tissues. This approach was also used in placenta‐derived human extravillous trophoblast cells derived from the third trimester (TCL1) and first trimester (HTR‐8) and term primary human cytotrophoblasts. Dual staining with Propidium Iodide (PI) and annexin V antibody was conducted to assess cell viability in TCL‐1 cells, HTR‐8 cells, and freshly isolated term primary human trophoblasts when exposed to serum samples from NP (NPS), PE (PES), and PES after complement inactivation by heating, heparin treatment, or blockade with antibodies. The expression levels of complement regulatory proteins, specifically decay‐accelerating factor (CD55), protectin (CD59), and membrane cofactor protein (CD46), on trophoblasts were quantified using Fluorescence‐activated cell sorting and immunohistochemistry.

Results

Substantial MAC deposition and a notable reduction in CD55 expression in the PE placenta compared to that from NP was observed, indicating heightened complement activation and impaired complement regulation in PE. Exposure to a significant subpopulation of PES (41%, n = 41) induced cell death exclusively in TCL‐1 cells, not in HTR‐8 cells and primary human trophoblasts. Remarkably, complement inactivation in PES abolished MAC deposition and rescued TCL‐1 cells from death, unequivocally implicating complement activity in trophoblast cell demise. Flow cytometry analysis disclosed lower levels of CD55 and CD59 expression in TCL‐1 cells in contrast to HTR‐8 cells and primary human trophoblasts. Blockade of CD55 and CD59 in HTR‐8 cells enhanced their susceptibility to PES‐induced cell death.

Conclusions

These findings underscore the significance of amplified complement activation, compromised complement inhibitory regulation, and consequent trophoblast cell death as potential contributors to the pathogenesis of PE. Strategies targeting dysregulated complement activity offer promising avenues for novel therapeutic interventions in PE management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pre-EclampsiaComplement ActivationPlacentaTrophoblastsHumansFemalePregnancyComplement Membrane Attack ComplexAdultCD55 AntigensCell LineCD59 AntigensComplement System Proteins

Stichwörter der Autor:innen

HTR8 cell lineTCL‐1 cell lineapoptosiscomplement regulatory proteinsmembrane attack complexpregnancyprimary human trophoblasts

Substanzen

Complement Membrane Attack ComplexCD55 AntigensCD59 AntigensComplement System Proteins

Autor:innen und Institutionen

  • Department of Pediatrics, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.
  • Women and Infants Hospital, Providence, Rhode Island, USA.
  • Keurig Dr Pepper, Frisco, Texas, USA.
  • Department of Molecular Biology, Cell Biology and Biochemistry, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.
  • Departments of Obstetrics and Gynecology and Pediatrics, University of Texas Medical Branch, Galveston, Texas, USA.

ORCID-Profile: Shibin Cheng, Lauren R Richardson, Surendra Sharma

Förderung

  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Cheng, S., Norris, W., Kalkunte, S., Jash, S., Richardson, L. R., & Sharma, S. (2025). Evidence for Complement Activation in Preeclampsia Placenta and Its Presence in Circulation. American Journal of Reproductive Immunology. https://doi.org/10.1111/aji.70076

Vancouver

Cheng S, Norris W, Kalkunte S, Jash S, Richardson LR, Sharma S. Evidence for Complement Activation in Preeclampsia Placenta and Its Presence in Circulation. American Journal of Reproductive Immunology. 2025. doi:10.1111/aji.70076

BibTeX
@article{Cheng2025,
  author = {Cheng, Shibin and Norris, Wendy and Kalkunte, Satyan and Jash, Sukanta and Richardson, Lauren R and Sharma, Surendra},
  title = {Evidence for Complement Activation in Preeclampsia Placenta and Its Presence in Circulation},
  journal = {American Journal of Reproductive Immunology},
  year = {2025},
  doi = {10.1111/aji.70076}
}
Kostenlos starten →